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All-Trans Retinoic Acid Shifts Propionibacterium
acnes-Induced Matrix Degradation Expression Profile
toward Matrix Preservation in Human Monocytes
H. Ray Jalian1, Philip T. Liu1, Melissa Kanchanapoomi1, Jenny N. Phan1, Annaliza J. Legaspi1
and Jenny Kim1,2
Propionibacterium acnes is a critical component in the pathogenesis of acne vulgaris, stimulating the
production of various inflammatory mediators, such as cytokines and chemokines, important in the local
inflammatory response found in acne. This study explored the role of P. acnes and its ability to induce matrix
metalloproteinases (MMPs) in primary human monocytes and how this induction is regulated by retinoids.
MMP-1- and MMP-9-expressing cells were present in perifollicular and dermal inflammatory infiltrates within
acne lesions, suggesting their role in acne pathogenesis. In vitro, we found that P. acnes induced MMP-9 and
MMP-1 mRNA, and the expression of MMP-9, but not of MMP-1, was found to be Toll-like receptor 2-dependent.
P. acnes induced the mRNA expression of tissue inhibitors of metalloproteinase (TIMP)-1, the main regulator of
MMP-9 and MMP-1. Treatment of monocytes with all-trans retinoic acid (ATRA) significantly decreased baseline
MMP-9 expression. Furthermore, co-treatment of monocytes with ATRA and P. acnes inhibited MMP-9 and
MMP-1 induction, while augmenting TIMP-1 expression. These data indicate that P. acnes-induced MMPs and
TIMPs may be involved in acne pathogenesis and that retinoic acid modulates MMP and TIMP expression,
shifting from a matrix-degradative phenotype to a matrix-preserving phenotype.
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INTRODUCTION
Activation of the innate immune system by cutaneous
pathogens leads to a direct host defense response, yet the
same mechanism is used by the pathogen to induce
inflammation and tissue injury that leads to disease. In acne
vulgaris, Propionibacterium acnes activates innate cells to
induce a protective antimicrobial response (Vowels et al.,
1995) but also contributes to disease by releasing various
inflammatory mediators including cytokines and chemokines
that lead to tissue injury. The release of these pro-
inflammatory mediators has been shown to be via a Toll-
like receptor (TLR)2-dependent mechanism (Kim et al.,
2002).
Recently, TLRs have been implicated in mediating the
expressions of various matrix metalloproteinases (MMPs)
(Kyburz et al., 2003; Gebbia et al., 2004; Elass et al., 2005).
MMPs play a role in numerous inflammatory conditions,
including rheumatoid arthritis (Burrage et al., 2006) and
atherosclerosis (Tayebjee et al., 2005). In addition, there is
evidence to support a role for MMPs in cutaneous microbial-
based diseases, such as Lyme disease (Hu et al., 2001) and
tuberculosis (Elkington et al., 2005). Increased levels of
MMP-1, MMP-3, and MMP-9 have been shown to be present
in acne lesions (Kang et al., 2005; Papakonstantinou et al.,
2005; Trivedi et al., 2006), but the role of MMPs in acne
pathogenesis is not clear.
Given the potential role for MMPs in inflammation, tissue
destruction, and scar formation (Kang et al., 2005), we
hypothesized that P. acnes may be an important stimulus for
MMPs in acne. We sought to explore the mechanism of
MMPs production, including the potential involvement of
TLRs and how retinoid therapy modulates MMPs in acne.
RESULTS
MMP expression in acne lesions
To determine whether MMPs play a role in acne pathogen-
esis, we sought to localize the expression of MMP-1 and
MMP-9 in vivo. Using immunohistochemistry, acne lesions
were obtained from patients and stained for MMPs. In
lesional skin, we found an abundance of MMP-1-expressing
cells predominantly in the inflammatory infiltrate at the base
of the pilosebaceous follicles (Figure 1). MMP-1 expression
was also detected in the inflammatory cells within the
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papillary dermis and the dermal–epidermal junction. The
expression of MMP-9 was noted to be similar, with the
perifollicular inflammatory infiltrate staining positive for
MMP-9 (Figure 1), although fewer in number than for
MMP-1. All three patient samples showed similar staining
patterns for both MMP-1 and MMP-9. In addition, the eccrine
glands stained positive for MMP-1 and MMP-9. Interestingly,
there was significant expression of MMP-9 in the upper layers
of the epidermis, when compared to isotype-matched
control. Sparse MMP-9 expression in single basal keratino-
cytes has been previously reported in normal skin samples
(Narbutt et al., 2006). This suggests that, in addition to the
inflammatory infiltrate, keratinocytes may also be a source of
MMP-9 in vivo in acne lesions.
P. acnes upregulates MMP-9 and MMP-1 gene expressions,
but not that of MMP-3
Given that MMP-expressing cells were mainly inflammatory
cells and various pathogens have shown to stimulate MMP
production in monocytes, we hypothesized that MMPs may
also be one of the mediators involved in P. acnes-induced
inflammatory response in acne. To test this, we isolated
monocytes from normal donors and determined relative
mRNA levels of various MMPs, including MMP-1, MMP-3,
and MMP-9, before and after stimulation with P. acnes
sonicate. Primary human monocytes expressed low levels of
MMP-1, MMP-3, and MMP-9 mRNA at baseline. Stimulation
of monocytes with P. acnes resulted in marked induction of
MMP-9 mRNA as measured by quantitative reverse tran-
scriptase PCR (RT-PCR) at all concentrations tested (Figure
2a). Stimulation of monocytes by P. acnes also induced
MMP-1 mRNA in a dose-dependent manner with a 16-fold
change at the highest concentration tested (Figure 2a).
Although MMP-9 and MMP-1 expression was upregulated,
no significant increase in MMP-3 mRNA was induced by P.
acnes (Figure 2a). Maximal upregulation of MMP-9 and
MMP-1 transcripts was seen between 12 and 16 hours (data
not shown).
Additionally, culture supernatants were analyzed at
48 hours after stimulation with P. acnes for MMP-9 and
MMP-1 protein. MMP-9 and MMP-1 were found to be
present in culture supernatants in a dose-dependant manner,
in agreement with the mRNA data (Figure 2b). The presence
of MMP-9 was approximately 100-fold greater in comparison
with MMP-1. Therefore, our data suggest that stimulation of
monocytes with P. acnes results in increased MMP-9 and
MMP-1 mRNA and protein expression.
Isotype Isotype
MMP-1MMP-9
Figure 1. MMP-9 and MMP-1 expression in acne lesions. Representative
sections from skin biopsy specimens from three acne patients with
inflammatory lesions were stained by the immunoperoxidase method with
mAbs specific for MMP-9 and MMP-1, or control antibodies, monoclonal
IgG1 and IgG2a, respectively. Two patient samples are shown with
MMP-expressing cells indicated by arrowheads. Samples from all three
patients showed similar staining patterns for MMP-9 and MMP-1.
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Figure 2. P. acnes induces MMP-9 and MMP-1 expression in monocytes, but
not that of MMP-3. (a) Primary human monocytes were stimulated with
various concentrations of P. acnes sonicate (0.01–1 mgml1) and mRNA was
harvested after 16 hours. mRNA levels of MMP-9, MMP-1, and MMP-3 were
determined using quantitative RT-PCR and normalized to the housekeeping
gene 36B4. Data is expressed as fold change over media and is a composite
of at least three independent experiments±SEM. (b) Primary human
monocytes were stimulated with various concentrations of P. acnes sonicate
(0.01–1 mgml1) and culture supernatants were harvested at 48 hours.
Samples were concentrated 10-fold and MMP-9 and MMP-1 levels were
determined by cytokine array (Pierce SearchLight Multiplex). Representative
experiment, 1 of 3, is shown. (P-values: *p0.05, **p0.01, zp0.001).
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MMP-9 gene expression, but not MMP-1, is TLR2 dependent
As P. acnes possesses a potent TLR2 ligand and is capable of
eliciting an immune response through a TLR2-dependent
mechanism (Kim et al., 2002), we sought to determine
whether TLR2 played any role in MMP expression. MMP-9
and MMP-1 mRNA were found to be expressed in monocytes
when stimulated with P. acnes as described previously.
However, when monocytes were pretreated for 1 hour with a
TLR2-neutralizing antibody, MMP-9 mRNA expression was
found to be o50% of the untreated value (Figure 3). In
contrast, the level of MMP-1 mRNA was not significantly
affected by pretreatment with a TLR2-neutralizing antibody
(Figure 3), suggesting different mechanisms for the regulation
of MMP-9 and MMP-1 transcription. Co-culture with murine
monoclonal IgG1 had no significant effect on either MMP-9
or MMP-1 expression.
P. acnes induces TIMP-1 mRNA expression, but not TIMP-2
The regulation of MMPs is complicated and occurs mainly
at the transcriptional level; however, regulation of MMP
protease activity is thought to be dependent on tissue
inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. We
sought to determine whether P. acnes has any affect on the
expression of TIMPs. We found that P. acnes induced a
marked upregulation of TIMP-1 mRNA in primary human
monocytes in a dose-dependent manner. A maximal 10-fold
upregulation of TIMP-1 was seen (Figure 4a). In contrast,
TIMP-2 expression was unaffected by P. acnes stimulation
(Figure 4a), suggesting that upregulation of TIMP-1 is specific
to P. acnes. This is consistent with our finding that P. acnes
specifically induced MMP-1 and MMP-9, and TIMP-1 is the
main regulator of these metalloproteinases, whereas TIMP-2
is thought to regulate MMP-2. We also found that TIMP-1
protein was markedly increased in P. acnes-treated cultures
in agreement with the mRNA data (Figure 4b).
All-trans retinoic acid regulates MMP and TIMP expression
One of the most common therapeutic agents used to treat
acne vulgaris are retinoic acid derivatives. In particular, all-
trans retinoic acid (ATRA) has been shown to have both anti-
inflammatory and anti-proliferative effects. Studies that
explored various inflammatory diseases suggest a role for
retinoids in the modulation of inflammation via MMP
regulation (Tsang and Crowe, 2001; Papakonstantinou
et al., 2005). Given the possible role of MMPs in inflamma-
tion, tissue remodeling, and subsequent scar formation in
acne, we explored the effects of ATRA on the induction of
MMPs and TIMPs by P. acnes.
We first sought to evaluate whether retinoids have any
effect on the baseline gene expression of MMPs or TIMPs.
Monocytes were treated with ATRA, or appropriate vehicle
control (DMSO) for 16 hours before determining the levels of
MMP and TIMP expression. We found that ATRA treatment
significantly downregulated the mRNA expression of MMP-9,
whereas the mRNA expressions of MMP-1 and MMP-3 were
not significantly affected (Figure 5a). Furthermore, TIMP-1
mRNA expression was increased by approximately 9-fold
in comparison with vehicle alone, whereas ATRA had no
significant effect on TIMP-2 (Figure 5a). These results suggest
that ATRA can modulate the gene expression of specific
MMPs and TIMPs, favoring the downregulation of MMP-9
with concomitant upregulation of TIMP-1.
Our earlier work demonstrated that ATRA has anti-
inflammatory properties, including inhibition of P. acnes-
induced production of pro-inflammatory cytokines IL-12 and
tumor necrosis factor-a by downregulating TLR2 and CD14
(Liu et al., 2005). We therefore hypothesized that ATRA may
also modulate the induction of MMPs by P. acnes. We
isolated human monocytes and treated the cells with P. acnes
either in the presence or absence of ATRA, then measured
MMP and TIMP mRNA expression. We found that there was
approximately 6-fold upregulation of MMP-9 and 10-fold up-
regulation of MMP-1 when monocytes were stimulated with
P. acnes. However, when cells were co-treated with P. acnes
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Figure 3. P. acnes-induced MMP-9, but not MMP-1, is TLR2 dependent.
Primary human monocytes were treated with media, TLR2 blocking Ab,
or isotype control Ab for 1 h before stimulation with P. acnes sonicate
(0.01mgml1), and 16 hours later, mRNA levels of MMP-9 and MMP-1 were
determined using quantitative RT-PCR and normalized to the housekeeping
gene 36B4. Data are expressed as percentage inhibition in MMP mRNA
expression when P. acnes-stimulated samples were compared with
media-treated samples and are a composite of three independent
experiments±SEM (P-value: *p0.05).
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Figure 4. P. acnes induces TIMP-1 but not TIMP-2 expression in monocytes.
(a) Primary human monocytes were stimulated with various concentrations of
P. acnes sonicate (0.01–1 mgml1) and mRNA was harvested after 16 hours.
mRNA levels of TIMP-1 and TIMP-2 were determined using quantitative
RT-PCR and normalized to the housekeeping gene 36B4. Data are expressed
as fold change over media and is a composite of at least three independent
experiments±SEM (P-value: *p0.05). (b) Culture supernatants were
harvested at 48 hours. Samples were concentrated 10-fold and TIMP-1 levels
were determined by cytokine array (Pierce SearchLight Multiplex).
Representative experiment, 1 of 3, is shown.
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and ATRA, there was approximately an 80% decrease in
MMP-9 and MMP-1 mRNA production in comparison with
P. acnes treatment alone (Figure 5b). Given the marked
upregulation of TIMP-1 mRNA by ATRA, next we explored
whether co-treatment of monocytes with ATRA and P. acnes
had any effect on TIMP-1 expression. Treatment of mono-
cytes with P. acnes resulted in a 5-fold increase in TIMP-1
expression, consistent with previous experiments. In addition,
monocytes treated with ATRA alone resulted in an approxi-
mately 10-fold increase in TIMP-1 mRNA. Co-treatment with
both ATRA and P. acnes resulted in an additive increase
(close to 15-fold) in TIMP-1 (Figure 5b). There was no
significant increase of TIMP-2 mRNA in either ATRA or
P. acnes treatment or with ATRA and P. acnes co-treatment
(Figure 5b). Taken together, these results suggest that ATRA
downregulates both P. acnes-induced MMP-9 and MMP-1
transcription, but augments P. acnes-induced TIMP-1 pro-
duction, shifting the gene expression profile from matrix
degradation (high MMP, low TIMP) toward a matrix
preservation (low MMP, high TIMP) profile.
DISCUSSION
Activation of the innate immune system by microbial
pathogens triggers host defense, but in addition it can lead
to tissue injury that contributes to disease pathology. In acne,
the host immune response to P. acnes is likely directed at
eliminating the bacteria but also leads to inflammation that
characterizes the clinical disease. In this study, we provide
evidence to support the induction of MMPs by P. acnes and
their presence in acne. We also demonstrate that ATRA, a
common therapeutic agent used in acne, is capable of
downregulating MMP-9 expression and upregulating its
inhibitor TIMP-1 in human monocytes, suggesting that ATRA
shifts the gene expression from a matrix degrading to a matrix
preserving profile. These data provide a mechanism for
inflammation and tissue injury in acne and a target for
therapeutic intervention.
The ability of microbial agents to induce expression of
matrix metalloproteinases has been shown in several experi-
mental systems and disease states, including Lyme disease,
pulmonary tuberculosis, and HIV infection (Gebbia et al.,
2004; Elkington et al., 2005; Webster and Crowe, 2006). In
our present study, we found that MMP-1 and MMP-9 are
present in acne lesions and that P. acnes is capable of
significantly upregulating their mRNA expression. Our data
are consistent with previous observation of MMP-1 and
MMP-9 in acne lesions (Kang et al., 2005; Papakonstantinou
et al., 2005; Trivedi et al., 2006). Although previous studies
have shown the presence of MMPs in acne lesions, our study
provides for the first time that P. acnes induces MMP
production in human monocytes. Although P. acnes activates
host innate immune cells to induce mediators such as
antimicrobial peptides for direct host defense and IL-12 to
instruct adaptive immune response, paradoxically, the
activation of immune cells also leads to inflammatory
response and tissue injury through the secretion of pro-
inflammatory cytokine production (Kim et al., 2002). The
upregulation of MMPs by P. acnesmay similarly contribute to
the inflammatory process and cause tissue destruction and
further lead to scar formation.
The specific mechanism by which P. acnes induces MMP
production is not yet certain, but our data suggest that pattern
recognition receptors, such as TLRs, play a role. Previously,
we have demonstrated that the production of cytokines such
as IL-12, IL-8, and tumor necrosis factor-a in monocytes by
P. acnes is TLR2 dependent (Kim et al., 2002). Furthermore,
pro-inflammatory cytokines, such as IL-8, IL-12, tumor
necrosis factor-a, and IL-1b are capable of MMP gene induc-
tion (Abraham et al., 2002; Ho et al., 2005). In our study, we
found that the expression of MMP-9 is TLR2 dependent,
whereas the upregulation of MMP-1 appeared to be TLR2
independent. Our finding is consistent with other published
data that two distinct mechanisms are involved in MMP-9
and MMP-1 expression (Gebbia et al., 2004).
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Figure 5. All-trans retinoic acid modulates MMP-9 and TIMP-1 expression in
monocytes. (a) Primary adherent monocytes were treated with 107 M ATRA,
and mRNA was harvested after 16 hours. mRNA levels of MMP-1, MMP-3,
MMP-9, TIMP-1, and TIMP-2 were determined using quantitative RT-PCR and
normalized to the housekeeping gene 36B4. Data are expressed as fold
change over control and are a composite of at three independent
experiments±SEM. (b) Primary adherent monocytes were co-treated with
107 M ATRA and P. acnes sonicate, and mRNA was harvested after 16 hours.
Levels of MMP-9, MMP-1, TIMP-1, and TIMP-2 were determined using
quantitative RT-PCR and normalized to the housekeeping gene 36B4. Data
are expressed as fold change over media and is a composite of at least three
independent experiments±SEM (P-values: *p0.05, **p0.01).
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ATRA, a common therapy used to treat acne, was shown
to modulate the induction of MMPs by P. acnes. The potent
anti-inflammatory property of retinoids seen in acne treat-
ment may be in part because of the inhibition of baseline
MMP-9 expression and also reductions of P. acnes-induced
MMP-9 and MMP-1 induction, with a simultaneous increase
in TIMP-1 expression. This is partially consistent with
previously published data that showed decreased MMP-9
expression in the sebum of patients treated with oral retinoids
(Papakonstantinou et al., 2005). While the investigators in the
previous study demonstrated no significant effect on TIMPs
with isotretinoin, we found that ATRA upregulated TIMP-1. It
has been proposed that aberrant MMP expression in acne
lesions account for increased collagen degradation, subse-
quent procollagen synthesis, imperfect repair, and scarring
(Kang et al., 2005). Moreover, other studies have demon-
strated that there is decreased TIMP expression in diabetic
ulcers and other poor-healing chronic wounds (Saarialho-
Kere, 1998; Vaalamo et al., 1999; Lobmann et al., 2002). Our
data indicate that ATRA shifts the expression profile from
matrix degradation to matrix preservation in vitro, and this
may translate to decreased scar formation in vivo. Although
further studies are warranted, it has been suggested that
retinoid-treated acne is less likely to scar than untreated acne
(Layton, 2001). Moreover, retinoid use has been shown to
improve acne scars in several clinical studies (Janssen de
Limpens, 1980; Mizutani et al., 1999; Schmidt et al., 1999).
It is interesting to consider the potential mechanisms for
retinoid regulation of MMPs. Our earlier study demonstrated
that retinoid treatment of monocytes downregulates TLR2
expression and also greatly diminishes P. acnes-induced
cytokine production (Liu et al., 2005). Similarly, retinoids
may also affect MMP expression through the modulation of
TLR2 expression and function. In addition, as retinoids
directly modulate activator protein-1 (AP-1)-mediated gene
expression (Fisher et al., 1998; Dedieu and Lefebvre, 2006)
and AP-1 promoter elements are present in MMP-1 and
MMP-9 (Birkedal-Hansen, 1995), regulation of AP-1 may
account for the decrease of MMP-9 seen with retinoid
treatment. This is consistent with the presence of activated
AP-1 in inflammatory acne lesions in vivo (Kang et al.,
2005). The mechanism by which retinoids modulate MMP
gene expression is currently under investigation in our
laboratory.
Acne is characterized by an inflammatory host response to
P. acnes, resulting in the production of cytokines, chemo-
kines, and MMPs. This inflammatory response results in
increased tissue destruction, imperfect repair, and subsequent
scarring, a significant long-term complication of acne. In this
article, we demonstrate that P. acnes induces MMPs, whereas
retinoids inhibit expression of these tissue degradative
enzymes and favor matrix preservation. It may be possible
that treatment of early acne lesions with retinoids could limit
subsequent scar formation. There are already clinical data to
support this hypothesis (Janssen de Limpens, 1980; Schmidt
et al., 1999; Layton, 2001; Sapadin and Fleischmajer, 2006).
In light of the importance of MMPs in inflammation and tissue
destruction, therapies aimed at targeting MMP expression or
activity may provide additional insights for the treatment of
acne and other inflammatory conditions.
MATERIALS AND METHODS
Reagents
ATRA (Sigma-Aldrich, St. Louis, MO) was diluted in DMSO to a stock
concentration of 102M and stored at 801C. Further dilutions were
made in amber tubes (USA Scientific, Ocala, FL) and aliquoted to
prevent repeated freeze–thaw cycles. All experiments were conducted
with 107M of ATRA as described previously (Liu et al., 2005). ATRA
treatment experiments were conducted concurrently with P. acnes
stimulation for 16hours. P. acnes strain 6919 was obtained from
American Type Culture Collection (Manassas, VA) and prepared by
probe sonication as described previously (Kim et al., 2002). The level of
endotoxin contaminating the P. acnes was quantified with a Limulus
Amoebocyte Lysate assay (BioWhittaker, Walkersville, MD) and found
to be o0.1ngml1. To activate TLR2, a synthetic 19-kDa lipopeptide
derived from Mycobacterium tuberculosis (EMC Microcollections) was
used (Brightbill et al., 1999). mAb specific to human TLR2 (clone 2392)
was provided by P.J. Godowski (Genentech, San Francisco, CA).
Monoclonal isotype specific controls were obtained from Sigma-Aldrich.
Primary human monocyte isolation and stimulation
Peripheral human blood was drawn from normal healthy volunteers
into heparinized tubes according to a protocol approved by the
Institutional Review Board at UCLA. Volunteers gave written
informed consent and the study was conducted according to
Declaration of Helsinki Principles. Peripheral blood mononuclear
cells were then isolated on Ficoll-Paque gradients (GE Healthcare,
Piscataway, NJ) and plated (5 106 per well) in 24-well plates for
2 hours in RPMI 1640 medium (Invitrogen Life Technologies,
Carlsbad, CA) supplemented with 1% FCS (Omega Scientific,
Tarzana, CA). Nonadherent cells were removed by washing three
times with RPMI. Adherent monocytes were cultured in 10% FCS
with P. acnes sonicate for 16 hours at 371C for RNA studies.
Forty-eight-hour cell culture supernatants were concentrated 10-
fold and assayed for MMP-1, MMP-9, and TIMP-1 using Pierce
SearchLight Multiplex Cytokine array services (Pierce Biotechnol-
ogy, Woburn, MA).
Quantitative RT-PCR
RNA was isolated from monocytes using TRIzol reagent (Invitrogen
Life Technologies), and cDNA was synthesized using the iScript
cDNA synthesis kit (Bio-Rad, Hercules, CA). Primers were designed
using Primer Express (Applied Biosystems, Foster City, CA) and can
be found in Supplementary Materials and Methods. SYBR Green
reactions were conducted with the IQ SYBR Green mix (Bio-Rad).
Reactions were run on the MJR Opticon Continuous Fluorescence
detector (Bio-Rad) and analyzed with Opticon Monitor Software
1.08 (Bio-Rad). The relative quantities of the gene tested per sample
were calculated against 36B4 using the DDC(T) formula as described
previously (Monney et al., 2002).
Samples from patients
After clinical diagnosis of acne, participants gave their written
informed consent, and inflamed acne lesions (papules and pustules)
were biopsied under local anesthesia using a 4-mm punch in
accordance with a protocol approved by the UCLA Institutional
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Review Board. Three acne samples (1 pustule and 2 papules) were
obtained from three different patients. The biopsies were snap-frozen
in liquid nitrogen and stored at 701C until sectioning. The study
was conducted according to the Declaration of Helsinki Principles.
Immunoperoxidase staining
Four-micrometer cryostat sections were acetone-fixed and blocked
with normal horse serum before incubation with the mAbs
for 60minutes, followed by biotinylated horse anti-mouse IgG
for 30minutes. Monoclonal MMP-1 and MMP-9 antibodies
were purchased from Chemicon International (Temecula, CA) and
isotype-matched irrelevant controls were purchased from Sigma
(St Louis, MO). Primary Abs were visualized with the ABC Elite
system (Vector Laboratories, Burlingame, CA), counterstained with
hematoxylin, and mounted in aqueous dry mounting medium
(Crystal Mount; Biomeda, Foster City, CA).
Statistical analysis
P-values were calculated using a two-tailed, paired Student’s t-test.
P-values p0.05 were considered significant.
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